HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States. The company owns, manages, and operates hospitals, ASCs, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, as well as rehabilitation and physical therapy centers, physician practices, home health agencies, hospices, outpatient physical therapy providers, home and community-based services providers, and various other facilities. Its general and acute care hospitals offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic services, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
Navigating Headwinds | Despite policy uncertainties affecting Medicaid coverage and potential OPPS cuts by 2028, HCA's strategic supply chain management and expansion initiatives position it well for continued success. |
Strategic Advantages | Delve into HCA's unique competitive edge through Galen College of Nursing ownership, which addresses healthcare staffing challenges by creating an internal pipeline of nursing talent. |
Growth Momentum | Explore HCA's impressive 11% EBITDA beat in Q3 2025 and sustainable 4-6% organic growth rate, with analyst price targets ranging from $366 to $494, averaging around $430. |
Healthcare Giant | HCA Healthcare stands as a dominant force in U.S. healthcare with a $107.9 billion market cap, operating an extensive network of hospitals and care centers with "GREAT" financial health. |
Metrics to compare | HCA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipHCAPeersSector | |
|---|---|---|---|---|
P/E Ratio | 16.1x | 18.4x | −0.5x | |
PEG Ratio | 0.56 | 0.77 | 0.00 | |
Price / Book | −18.1x | 4.3x | 2.6x | |
Price / LTM Sales | 1.4x | 1.8x | 3.2x | |
Upside (Analyst Target) | 13.5% | 35.6% | 45.7% | |
Fair Value Upside | Unlock | 7.2% | 4.8% | Unlock |